trending Market Intelligence /marketintelligence/en/news-insights/trending/tA60RMeVxHmJcsb42nio5g2 content esgSubNav
In This List

Lansen Pharmaceutical buys 20% stake in Chinese company

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Lansen Pharmaceutical buys 20% stake in Chinese company

China's Lansen Pharmaceutical Holdings Ltd. said it bought a 20% stake in Tianjin Robustnique Biotechnology Co. Ltd., a producer of cosmetics and biological skincare products that also operates in the country.

Lansen Pharmaceutical, an investment holding company that develops, produces and sells specialty pharmaceuticals, paid 14 million Chinese yuan for the stake.

London-listed Cathay International Holdings Ltd., an investment holding company that invests in China's healthcare sector, owns a little over half of Lansen Pharmaceutical.

As of Dec. 28, US$1 was equivalent to 6.88 Chinese yuan.